(-0.01%) 5 206.00 points
(0.06%) 39 019 points
(-0.21%) 18 157 points
(-0.28%) $78.26
(0.82%) $2.21
(-0.33%) $2 323.40
(-0.43%) $27.50
(-0.05%) $964.40
(0.07%) $0.929
(0.37%) $10.86
(0.17%) $0.797
(-0.36%) $91.02
0.13% € 75.59
Live Chart Being Loaded With Signals
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software...
Stats | |
---|---|
Volumen de hoy | 359.00 |
Volumen promedio | 957.00 |
Capitalización de mercado | 100.37B |
EPS | €0.682 ( 2023-10-31 ) |
Próxima fecha de ganancias | ( €0 ) 2024-05-23 |
Last Dividend | €0.690 ( 2023-09-21 ) |
Next Dividend | €0 ( N/A ) |
P/E | 25.80 |
ATR14 | €0.194 (0.26%) |
Medtronic PLC Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Medtronic PLC Finanzas
Annual | 2022 |
Ingresos: | €31.23B |
Beneficio Bruto: | €20.51B (65.67 %) |
EPS: | €2.83 |
FY | 2022 |
Ingresos: | €31.23B |
Beneficio Bruto: | €20.51B (65.67 %) |
EPS: | €2.83 |
FY | 2022 |
Ingresos: | €31.69B |
Beneficio Bruto: | €21.54B (67.98 %) |
EPS: | €3.75 |
FY | 2021 |
Ingresos: | €30.12B |
Beneficio Bruto: | €19.63B (65.19 %) |
EPS: | €2.69 |
Financial Reports:
No articles found.
Medtronic PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0.680 (N/A) |
€0.680 (N/A) |
€0.680 (N/A) |
€0.690 (N/A) |
€0.690 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.320 | 2008-03-26 |
Last Dividend | €0.690 | 2023-09-21 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 58 | -- |
Total Paid Out | €24.44 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.01 | -- |
Div. Sustainability Score | 9.19 | |
Div.Growth Potential Score | 3.66 | |
Div. Directional Score | 6.43 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RNT.F | Ex Dividend Junior | 2023-09-13 | Annually | 0 | 0.00% | |
BIRG.DE | Ex Dividend Junior | 2023-05-11 | Sporadic | 0 | 0.00% | |
ITU.DE | Ex Dividend Knight | 2023-10-06 | Quarterly | 0 | 0.00% | |
TNE5.DE | Ex Dividend Junior | 2023-12-12 | Semi-Annually | 0 | 0.00% | |
CSH.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
MBB.DE | Ex Dividend Junior | 2023-06-13 | Annually | 0 | 0.00% | |
WIB.DE | Ex Dividend Knight | 2023-05-09 | Annually | 0 | 0.00% | |
ENI.DE | Ex Dividend Knight | 2023-11-20 | Semi-Annually | 0 | 0.00% | |
OPC.DE | Ex Dividend Knight | 2023-09-07 | Quarterly | 0 | 0.00% | |
ADM.DE | Ex Dividend Knight | 2023-08-15 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.130 | 1.500 | 7.40 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0462 | 1.200 | 8.46 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0816 | 1.500 | -0.204 | -0.307 | [0.1 - 1] |
payoutRatioTTM | 0.871 | -1.000 | 1.293 | -1.293 | [0 - 1] |
currentRatioTTM | 2.30 | 0.800 | 3.51 | 2.80 | [1 - 3] |
quickRatioTTM | 1.459 | 0.800 | 6.12 | 4.90 | [0.8 - 2.5] |
cashRatioTTM | 0.166 | 1.500 | -0.190 | -0.286 | [0.2 - 2] |
debtRatioTTM | 0.277 | -1.500 | 5.38 | -8.07 | [0 - 0.6] |
interestCoverageTTM | 8.05 | 1.000 | 8.13 | 8.13 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.87 | 2.00 | 8.38 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.71 | 2.00 | 8.15 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.486 | -1.500 | 8.06 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.655 | 1.000 | 2.42 | 2.42 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.175 | 1.000 | 8.50 | 8.50 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.257 | 1.000 | 9.68 | 9.68 | [0.2 - 2] |
assetTurnoverTTM | 0.356 | 0.800 | -0.961 | -0.769 | [0.5 - 2] |
Total Score | 9.19 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 25.74 | 1.000 | 7.50 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0816 | 2.50 | -0.131 | -0.307 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.71 | 2.00 | 8.76 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.39 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.87 | 2.00 | 8.38 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.871 | 1.500 | 1.293 | -1.293 | [0 - 1] |
pegRatioTTM | -0.974 | 1.500 | -9.83 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.200 | 1.000 | 7.50 | 0 | [0.1 - 0.5] |
Total Score | 3.66 |
Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico